newsfilter
← Latest News
Business Wire·

Omeros Corporation Announces Update on European Marketing Authorization Application for Narsoplimab in TA-TMA

Omeros Corporation (NASDAQ:OMER) announced today an update on the review by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) of the company’s marketing authorization